@article{JTD18986,
author = {Servet Bölükbas and Michael Eberlein},
title = {Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Macroscopic complete resection (MCR) is the goal of surgery and seems to have the most significant effect on survival in patients undergoing surgery-directed multimodality treatment (MMT) for malignant pleural mesothelioma (MPM) (1). For the authors, it is not questionable that Dr. David J. Sugarbaker and his team had, have and will have a significant impact on the term MCR and the surgery-directed MMT, respectively.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/18986}
}